EIS is the member of the duo focused more heavily on familiar, blue chip Israeli stocks such as Teva Pharmaceuticals (NasdaqGM: TEVA).
On the other hand, ISRA could be seen as the play on a new Israel with its almost 31% weight to the technology sector. ISRA is far more levered to the Israeli startup boom with a 31.5% weight to tech stocks. ISRA is also home to nearly 30 more holdings than EIS, giving the new Israel a broader cap reach, which could be seen as a sign that if a spate of Israeli IPOs come to market, some could eventually find a home in ISRA. [Israel’s Startup Scene Could Boost This ETF]
Market Vectors Israel ETF
ETF Trends editorial team contributed to this post.